Results 101 to 110 of about 9,874 (219)

Immunogenicity and safety of a monovalent, multicomponent acellular pertussis vaccine in 15 month-6-year-old German children : monovalent acellular pertussis vaccine study group

open access: yes, 1995
Immunization against pertussis has been re-recommended for healthy children in Germany in 1991. In addition the former restriction of immunizing only in the first 2 years of life was abolished.
Angersbach, P.   +5 more
core  

ADULT IMMUNIZATION WITH ACELLULAR PERTUSSIS VACCINE

open access: yesThe Pediatric Infectious Disease Journal, 1993
Objective. —To evaluate the safety and immunogenicity in adults of several different concentrations of an acellular pertussis vaccine. Design. —Double-blind, randomized, placebo-controlled trial. Setting. —Medical center immunization clinic. Participants. —One hundred eighteen healthy adult volunteers. Interventions.
openaire   +2 more sources

Overdose and intramuscular administration of Bacille Calmette-Guerin vaccine in a 2-month-old infant

open access: yesThe Turkish Journal of Pediatrics, 2014
The Bacille Calmette-Guérin (BCG) vaccine is used against tuberculosis. According to the vaccination program in Turkey, DaBT-Hib-IPV (diphtheriapertussis [acellular]-tetanus-haemophilus influenza type b-inactive poliovaccine), PVC13 (pneumoccocal ...
Güniz Yaşöz   +2 more
doaj  

[Acellular pertussis vaccine].

open access: yesZhurnal mikrobiologii, epidemiologii i immunobiologii, 2008
Protective, immunogenic, toxic, and sensitizing properties of acellular pertussis vaccine (aPV) developed according to original technology were studied, aPV had marked protective activity which lasted more than 2 years. Sera of mice immunized by aPV also possess protective properties, and they were more prominent than in sera of mice immunized by ...
N S, Zakharova   +7 more
openaire   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Development of An Acellular Pertussis-vaccine and its Administration As a Booster in Healthy-adults

open access: yes, 1991
An acellular pertussis vaccine which contains highly purified pertussis toxoid (PT) and filamentous haemagglutinin (FHA) has been developed. These proteins have been shown to be stable, with essentially no significant reversion of the pertussis toxoid ...
Puttolaurila, A.   +20 more
core   +1 more source

Intranasal Acellular Pertussis Vaccine Provides Mucosal Immunity and Protects Mice from Bordetella Pertussis

open access: yes, 2019
Current acellular pertussis vaccines fall short of optimal protection against the human respiratory pathogen Bordetella pertussis resulting in increased incidence of a previously controlled vaccine- preventable disease.
Basinger, Hayden D.   +30 more
core   +1 more source

Local reactions to the acellular diphtheria tetanus pertussis vaccine in pre-school children are associated with vaccine-specific Th2 memory responses

open access: yes, 2005
Local reactions to the acellular diphtheria tetanus pertussis vaccine in pre-school children are associated with vaccine-specific Th2 memory ...
PG Holt (14457411)   +5 more
core  

Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children

open access: yes, 2006
ObjectiveThe aim of this study was to determine the site, extent, and resolution of tissue involvement when extensive limb swelling occurred in the injected limb for children who received diphtheria-tetanus-acellular pertussis or reduced-antigen content ...
Gent, R.   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy